Phosphatidylinositol 3-kinase mediates heregulin-induced growth inhibition in human epithelial cells

被引:0
作者
Hamburger, AW
Yoo, JY
机构
[1] UNIV MARYLAND,DEPT PATHOL,BALTIMORE,MD 21201
[2] UNIV MARYLAND,PROGRAM MOL & CELL BIOL,BALTIMORE,MD 21201
关键词
breast cancer; erbB receptors; heregulin; phosphatidylinositol; 3-kinase;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Activation of phosphatidylinositol 3-kinase (PI-3K) has been shown to be critical for heregulin induced mitogenesis of human breast epithelial cells. However, the inhibitory effects of HRG have not been linked to PI3K activation The purpose of these experiments was to determine the effects of heregulin beta 1 (HRG) on growth and PI3K activation of a nonneoplastic human mammary epithelial cell line, 184B5. The results of these experiments indicated that low concentrations of HRG increased the growth of 184B5 cells three fold, while high concentrations inhibited growth by 50%. HRG at all concentrations tested increased tyrosine phosphorylation of erbB3. Similarly, HRG at all concentrations stimulated the association of PI3K with erbB3. Wortmannin, an inhibitor of PI3K enzymatic activity, reversed both the inhibitory and stimulatory effects of HRG on incorporation of [H-3] thymidine into DNA. We conclude that both the growth inhibitory and stimulatory effects of HRG in nonneoplastic human mammary epithelial cells are mediated by activation of PI3K.
引用
收藏
页码:2197 / 2200
页数:4
相关论文
共 50 条
  • [41] Activation of NF-κB binding in HT-29 colon cancer cells by inhibition of phosphatidylinositol 3-kinase
    Wang, QD
    Kim, SH
    Wang, XF
    Evers, BM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (03) : 853 - 858
  • [42] Inhibition of phosphatidylinositol 3-kinase causes apoptosis in retinoic acid-differentiated HL-60 leukemia cells
    Ma, J
    Liu, Q
    Zeng, YX
    CELL CYCLE, 2004, 3 (01) : 67 - 70
  • [43] Involvement of phosphatidylinositol 3-kinase in NFAT activation in T cells
    Jascur, T
    Gilman, J
    Mustelin, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (22) : 14483 - 14488
  • [44] Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells
    Saward, L
    Zahradka, P
    CIRCULATION RESEARCH, 1997, 81 (02) : 249 - 257
  • [45] Class IA Phosphatidylinositol 3-Kinase Inhibition Inhibits Cell Growth and Proliferation in Mantle Cell Lymphoma
    Tabe, Yoko
    Jin, Linhua
    Konopleva, Marina
    Shikami, Masato
    Kimura, Shinya
    Andreeff, Michael
    Raffeld, Mark
    Miida, Takashi
    ACTA HAEMATOLOGICA, 2014, 131 (01) : 59 - 69
  • [46] RNA Interference-Mediated Silencing of the Phosphatidylinositol 3-Kinase Catalytic Subunit Attenuates Growth of Human Ovarian Cancer Cells in vitro and in vivo
    Zhang, Xi
    Deng, Hong-xin
    Zhao, Xia
    Su, Dan
    Chen, Xian-chen
    Chen, Li-juan
    Wei, Yu-quan
    Zhong, Qian
    Li, Zheng-yu
    He, Xiang
    Yi, Tao
    ONCOLOGY, 2009, 77 (01) : 22 - 32
  • [47] Insulin Secretion Induced by Glucose-dependent Insulinotropic Polypeptide Requires Phosphatidylinositol 3-Kinase γ in Rodent and Human β-Cells
    Kolic, Jelena
    Spigelman, Aliya F.
    Smith, Alannah M.
    Fox, Jocelyn E. Manning
    MacDonald, Patrick E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (46) : 32109 - 32120
  • [48] Further evidence for the involvement of insulin receptor substrates in epidermal growth factor-induced activation of phosphatidylinositol 3-kinase
    Fujioka, T
    Kim, JH
    Adachi, H
    Saito, K
    Tsujimoto, M
    Yokoyama, S
    Ui, M
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (15): : 4158 - 4168
  • [49] Lysophosphatidylcholine generates superoxide anions through activation of phosphatidylinositol 3-kinase in human neutrophils
    Nishioka, H
    Horiuchi, H
    Arai, H
    Kita, T
    FEBS LETTERS, 1998, 441 (01) : 63 - 66
  • [50] Lysophosphatidylcholine generates superoxide anions through activation of phosphatidylinositol 3-kinase in human neutrophils
    Nishioka, H
    Horiuchi, H
    Arai, H
    Kita, T
    LIPOPROTEIN METABOLISM AND ATHEROGENESIS, 2000, : 263 - 265